JP2022535102A5 - - Google Patents

Info

Publication number
JP2022535102A5
JP2022535102A5 JP2021571915A JP2021571915A JP2022535102A5 JP 2022535102 A5 JP2022535102 A5 JP 2022535102A5 JP 2021571915 A JP2021571915 A JP 2021571915A JP 2021571915 A JP2021571915 A JP 2021571915A JP 2022535102 A5 JP2022535102 A5 JP 2022535102A5
Authority
JP
Japan
Prior art keywords
polypeptide
cancer
polynucleotide
composition
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021571915A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022535102A (ja
JP7758573B2 (ja
Filing date
Publication date
Priority claimed from GBGB1908012.6A external-priority patent/GB201908012D0/en
Application filed filed Critical
Publication of JP2022535102A publication Critical patent/JP2022535102A/ja
Publication of JP2022535102A5 publication Critical patent/JP2022535102A5/ja
Priority to JP2025170954A priority Critical patent/JP2026010046A/ja
Application granted granted Critical
Publication of JP7758573B2 publication Critical patent/JP7758573B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021571915A 2019-06-05 2020-06-04 Tgf-ベータワクチン Active JP7758573B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025170954A JP2026010046A (ja) 2019-06-05 2025-10-09 Tgf-ベータワクチン

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1908012.6A GB201908012D0 (en) 2019-06-05 2019-06-05 TGF-Beta vaccine
GB1908012.6 2019-06-05
PCT/EP2020/065472 WO2020245264A1 (en) 2019-06-05 2020-06-04 Tgf-beta vaccine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025170954A Division JP2026010046A (ja) 2019-06-05 2025-10-09 Tgf-ベータワクチン

Publications (3)

Publication Number Publication Date
JP2022535102A JP2022535102A (ja) 2022-08-04
JP2022535102A5 true JP2022535102A5 (cg-RX-API-DMAC7.html) 2023-06-14
JP7758573B2 JP7758573B2 (ja) 2025-10-22

Family

ID=67385796

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021571915A Active JP7758573B2 (ja) 2019-06-05 2020-06-04 Tgf-ベータワクチン
JP2025170954A Pending JP2026010046A (ja) 2019-06-05 2025-10-09 Tgf-ベータワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025170954A Pending JP2026010046A (ja) 2019-06-05 2025-10-09 Tgf-ベータワクチン

Country Status (12)

Country Link
US (1) US20220315634A1 (cg-RX-API-DMAC7.html)
EP (1) EP3980449A1 (cg-RX-API-DMAC7.html)
JP (2) JP7758573B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220018566A (cg-RX-API-DMAC7.html)
CN (1) CN113966342B (cg-RX-API-DMAC7.html)
AU (2) AU2020287902B9 (cg-RX-API-DMAC7.html)
CA (1) CA3141744A1 (cg-RX-API-DMAC7.html)
GB (1) GB201908012D0 (cg-RX-API-DMAC7.html)
IL (1) IL288673A (cg-RX-API-DMAC7.html)
MX (1) MX2021014856A (cg-RX-API-DMAC7.html)
SG (1) SG11202112416XA (cg-RX-API-DMAC7.html)
WO (1) WO2020245264A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021409832A1 (en) * 2020-12-23 2023-08-10 Korea Institute Of Science And Technology NOVEL PEPTIDE CAPABLE OF INHIBITING TGF-β SIGNALING AND USE THEREOF
US20250327041A1 (en) 2022-02-24 2025-10-23 Io Biotech Aps Nucleotide delivery of cancer therapy
US20250339504A1 (en) * 2022-05-18 2025-11-06 National Cancer Center Cancer vaccine with use of common cancer antigen cocktail, tcr/car-t cell therapeutic, companion diagnostic method, and method for diagnosing risk of cancer onset by detecting circulating tumor cells
GB202215997D0 (en) 2022-10-28 2022-12-14 Io Biotech Aps Therapy
GB202216449D0 (en) 2022-11-04 2022-12-21 Io Biotech Aps TGF-BETA1 vaccine

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US58767A (en) 1866-10-16 John brougjbton
US5554372A (en) 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5420243A (en) * 1993-01-26 1995-05-30 Celtrix Pharmaceuticals, Inc. Biologically active TGF-β2 peptides
EP0877031A1 (en) * 1997-05-06 1998-11-11 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) TGF-Beta1 derived peptides mimicking the activity of transforming growth factor-Beta1
EP0922710A4 (en) * 1997-05-12 2002-10-25 Kyowa Hakko Kogyo Kk PEPTIDES SUPPORTING THE ACTIVATION OF LATENT TGF-BETA AND A METHOD FOR IDENTIFYING REGULATORS OF TGF-BETA ACTIVITY.
US6500920B1 (en) * 1997-06-19 2002-12-31 St. Louis University Inhibitor of transforming growth factor β and A method of inhibiting the biological effects of transforming growth factor
ES2146552B1 (es) * 1998-11-24 2001-04-16 Inst Cientifico Tecnol Navarra Peptidos inhibidores de tgf/31
AU2001246393A1 (en) * 2000-03-31 2001-10-08 Vaccine Chip Technology Aps Immunostimulating properties of a fragment of tgf-beta
US8158589B2 (en) * 2003-08-22 2012-04-17 Proyecto Biomedicine Cima, S.L. Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1)
WO2005105144A1 (ja) * 2004-04-30 2005-11-10 Kyowa Hakko Kogyo Co., Ltd. 潜在型TGF-βの活性化抑制剤
AU2005337776B2 (en) * 2005-10-24 2013-01-31 Proyecto De Biomedicina Cima, S.L. Use of TGF-Beta1 inhibitor peptides in the preparation of an immune response modulating agent
JP2011519266A (ja) * 2008-03-21 2011-07-07 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 免疫反応の調節
RU2012107535A (ru) * 2009-07-30 2013-09-10 Антисенс Фарма Гмбх КОМБИНАЦИЯ ХИМИОТЕРАПЕВТИЧЕСКОГО СРЕДСТВА И ИНГИБИТОРА СИСТЕМЫ TGF-β
CN103087173B (zh) * 2013-01-16 2014-07-16 西安交通大学医学院第一附属医院 基于TGF-β1的B细胞抗原表位的合成肽疫苗及其应用
HRP20201914T1 (hr) * 2013-05-06 2021-01-22 Scholar Rock, Inc. Sastavi i postupci za modulaciju faktora rasta
EP4050020A1 (en) * 2014-03-11 2022-08-31 University of Florida Research Foundation, Inc. Aav-expressed m013 protein as an anti-inflammatroy therapeutic for use in a method of treating inflammatory ocular disease
AU2017254477A1 (en) * 2016-04-18 2018-11-01 Jennifer G. ABELIN Improved HLA epitope prediction

Similar Documents

Publication Publication Date Title
US7871816B2 (en) Vector for anti-HPV vaccine and transformed microorganism by the vector
JP2003518931A (ja) Hivに対する免疫応答における改善、または免疫応答に関する改善
ES2373055T3 (es) Péptido antígeno de rechazo de cáncer derivado de glipican-3 (gpc3) para uso en pacientes positivos a la hla-a2 y producto farmacéutico que comprende el antígeno.
EP2391383B1 (en) Codon-optimized hepatitis b virus core antigen (hbcag)
RU2007119319A (ru) Наборы антигенов полипептида, угнетающего секрецию желудка (gip), и их применение
EA016818B1 (ru) Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1
JP2022507373A5 (cg-RX-API-DMAC7.html)
JP2024513559A5 (cg-RX-API-DMAC7.html)
CN117987471A (zh) 一种重组病毒载体、包含其的免疫组合物以及用途
CA2432971A1 (en) Polypeptides
CA2106093A1 (en) Recombinant anticoccidial vaccine
CN107510841B (zh) 源头阻断包虫病病原细粒棘球绦虫传播的疫苗
CN105073989A (zh) 免疫原性多肽表层表达双歧杆菌
US8207141B2 (en) Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof
JP2009520472A (ja) 腫瘍抗原由来最適化潜在性ペプチドで構成される免疫原性ポリペプチド及びその使用
JP2003522195A (ja) 肝細胞癌の治療のための方法及び組成物
CN114805607A (zh) EGFRvIII-PDL1-GMCSF肿瘤疫苗及其制备方法和应用
JP4459060B2 (ja) ポリヌクレオチドからなるワクチン
CN104974247B (zh) 人肺靶向性抗肺泡表面活性蛋白a的纳米抗体及其制备方法
CN101302524A (zh) 弓形虫多表位基因与霍乱毒素ctxa2/b亚基的融合基因及应用
JP2002510496A (ja) 細胞傷害性t細胞を誘導するための医薬
RU2005101744A (ru) Последовательность днк и получение аллергена пыльцы трав ph1 p4 с помощью рекомбинантных способов
JPWO2007018198A1 (ja) Hla−a2陽性者用hsp105由来癌拒絶抗原ペプチド及びこれを含む医薬
CN102838679A (zh) Her2-neu抗原阳性肿瘤治疗性疫苗的制备及应用
Milani et al. HSP roles as biomarkers and antigens in bacterial and viral infections